Lab parameters–Significant reduction in means. by Harleen Kaur (288288)

“…</p><p>Registry: The study was registered on the <a href="http://ctri.nic.in/Clinicaltrials" target="_blank">http://ctri.nic.in/Clinicaltrials</a> website under identifier number: CTRI/2020/12/029668 on 9th December 2020.…”

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Reduction of NPIs by >50% may result increased transmission and significant mortality. by Benjamin U. Hoffman (5470583)

Example of predicted effects of choice bundling on preference for larger, later rewards (LLRs) over smaller, sooner rewards (SSRs). by Jeffrey S. Stein (11689918)

Perinatal outcomes from January 2017 to December 2019 (pre-policy period: January-December 2017; post-policy period: January 2018-December 2019). by Ingvild Hersoug Nedberg (11384048)

Subjects:

Cesarean section rates from January 2017 to December 2019 (pre-policy period: January-December 2017; post-policy period: January 2018-December 2019). by Ingvild Hersoug Nedberg (11384048)

Subjects:

Demographic presentation of the study population in the pre- (January-December 2017) and post-policy (January 2018-December 2019) periods. by Ingvild Hersoug Nedberg (11384048)

Subjects:

Baseline rates, trends, and changes in NICU transfer rates and perinatal mortality rates for cesarean section and vaginal births in the pre- (January-December 2017) and post-policy... by Ingvild Hersoug Nedberg (11384048)

Subjects:

Baseline rates, trends, and changes in cesarean section rates in the pre- (January-December 2017) and post-policy (January 2018-December 2019) period, including cumulative effect 2... by Ingvild Hersoug Nedberg (11384048)

Subjects:

Studies with significant burnout reduction at different follow up time points (n=24). by Ili Binti Abdullah Sharin (21299781)

Decrease of admissions and lead diagnoses. by Petr Fulin (8380320)

Subjects:

Optimal changes in carbohydrate and fat intake for targeted weight reduction. by Julia H. Chen (16745256)

Sensitivity analyses of seroprevalence with the largest sample size study omitted. by Yu Zhou (89766)

Medication target-action pairs significantly inversely associated with neurodegenerative condition(s) and ≥20% average reduction in relative risk, U.S.... by Yizhe Song (11859734)

“…<p>Medication target-action pairs significantly inversely associated with neurodegenerative condition(s) and ≥20% average reduction in relative risk, U.S. …”

Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Motif enrichment in significantly altered phospho-proteomic data. by Jacob M. Wozniak (4900267)

An observer’s steady- and pulsed-pedestal threshold data and model fits: (1) steady-pedestal paradigm (MC pathway) non-flicker adaptation condition (open circle); (2) steady-pedest... by Xiaohua Zhuang (11890694)

Subjects:

Phospho-protein Families with Numerous Significantly-Altered Phospho-peptides. by Jacob M. Wozniak (4900267)